chevron_leftBack
G
As of 7 June 2026, Goldline Pharmaceutical Ltd. has a market cap of $4.86M USD, ranking #44602 globally and #3871 in India.
It ranks #3953 in the Healthcare sector, and #197 in the Medical Distribution industry.
Key Stats
Market Cap
$4.86MUSD
465.02M INR
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -5% | -0.5% | -23% | -23% | -23% | -23% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
GLPL
ISIN: INE1CLW01015
Shares Out.:
Shares Outstanding:
9.6M1
|
46.02 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: ENTERO
|
$541.39M
11K%
51.84B INR
|
46.1
|
|
BSE: APPL
|
$33.19M
583%
3.18B INR
|
-
|
|
BSE: 524723
|
$27.7M
470%
2.65B INR
|
-
|
|
BSE: 524790
|
$27.37M
464%
2.62B INR
|
44.6
|
|
NSE: VIJAYPD
|
$21.22M
337%
2.03B INR
|
27.1
|
|
BSE: 523289
|
$19.35M
298%
1.85B INR
|
36.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MCK
|
$100.76B
2M%
|
24.0
|
|
NYSE: COR
|
$60.58B
1M%
|
37.4
|
|
NYSE: CAH
|
$47.73B
983K%
|
29.6
|
|
NASDAQ: HSIC
|
$8.47B
174K%
|
22.6
|
|
SHEK: 1099
|
$7.48B
154K%
58.61B HKD
|
7.2
|
|
SIX: GALE
|
$5.32B
110K%
4.2B CHF
|
23.0
|
chevron_leftBack